Laboratory of Vascular Biology, Health Institute (InCor), University of Sao Paulo School of Medicine, Sao Paulo, Brazil.
Departamento de Medicina Preventiva, Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil.
PLoS One. 2022 Jun 22;17(6):e0269549. doi: 10.1371/journal.pone.0269549. eCollection 2022.
We have examined the impact of changes in modifiable risk factors on CVD mortality in 26 Brazilian states from 2005 to 2017.
Data were acquired from the Global Burden of Diseases study (GBD) and official sources of the Brazilian government, totalling 312 state-year observations. Population attributable fractions (PAFs) were calculated to determine the number of deaths attributed to changes in each risk factor. Fixed-effects multivariable linear regression models were performed, adjusting for income, income inequality, poverty and access to healthcare.
Between 2005 and 2017, CVD deaths reduced by 21.42%, accompanied by a decrease in smoking (-33%) and increases in hyperglycaemia (+9.5%), obesity (+31%) and dyslipidaemia (+5.2%). Reduction in smoking prevented or postponed almost 20,000 CVD deaths in this period, while increased hyperglycaemia exposure resulted in more than 6,000 CVD deaths. The association between hyperglycaemia and CVD mortality was 5 to 10 times higher than those found for other risk factors, especially in women (11; 95%CI 7 to 14, deaths per 1-point increase in hyperglycaemia exposure). Importantly, the association between hyperglycaemia and CVD mortality was independent of socioeconomic status and access to healthcare, while associations for other risk factors after the same adjustments.
Reduction in smoking was the risk factor that led to the highest number of CVD deaths prevented or postponed, while hyperglycaemia showed the most deleterious association with CVD mortality. Health policies should aim to directly reduce the prevalence of hyperglycaemia to mitigate the population burden of CVD in Brazil in the future.
我们研究了 2005 年至 2017 年期间巴西 26 个州可改变风险因素变化对心血管疾病死亡率的影响。
数据来自全球疾病负担研究(GBD)和巴西政府的官方来源,共获得 312 个州年观测值。计算人群归因分数(PAF)以确定每个风险因素变化导致的死亡人数。采用固定效应多变量线性回归模型,调整收入、收入不平等、贫困和医疗保健可及性因素。
2005 年至 2017 年间,心血管疾病死亡率下降了 21.42%,同时吸烟率下降(-33%),高血糖症(+9.5%)、肥胖症(+31%)和血脂异常(+5.2%)率上升。在此期间,减少吸烟预防或推迟了近 2 万例心血管疾病死亡,而高血糖暴露增加导致了超过 6000 例心血管疾病死亡。高血糖与心血管疾病死亡率之间的关联是其他风险因素的 5 到 10 倍,尤其是女性(11;95%CI 7 至 14,每增加 1 个点的高血糖暴露导致的心血管疾病死亡数)。重要的是,高血糖与心血管疾病死亡率之间的关联独立于社会经济地位和医疗保健可及性,而其他风险因素在进行相同调整后则与心血管疾病死亡率相关。
减少吸烟是导致预防或推迟心血管疾病死亡人数最多的风险因素,而高血糖症与心血管疾病死亡率的关联最具危害性。未来的卫生政策应旨在直接降低高血糖症的流行率,以减轻巴西心血管疾病的人群负担。